Liane Preussner

Liane Preussner joined Immatics in January 2025 and is responsible for the clinical development division, including medical, pharmacovigilance, clinical science and data management functions.

Liane brings 15 years of experience in clinical development in the pharmaceutical and biotech industries. Most recently, she worked at BioNTech, where she was responsible for the clinical development of cell therapies (BNT211, CLDN6-CARTs) as well as personalized cancer vaccines (BNT122) for various solid tumors.

Her passion for cell therapies emerged during her time at Miltenyi Biotec where her teams brought several CAR T programs in hemato-oncology (CD19, CD20, CD2019) to the clinic. Liane has a broad understanding of the regulatory framework for advanced therapies, pharmacovigilance and clinical operations.

Liane Preussner holds a Medical Degree from the University of Cologne, Germany.